Company: CCHH
Filing Date: 2025-06-26
Form Type: DRS
Source: 0001213900-25-058036
Chunk: 2

Company: CCH Holdings Ltd
Filing Date: 2025-06-26
Form: DRS
Chunk 2
---
 apply to list our ordinary shares on the Nasdaq Capital Market (“Nasdaq”) under the symbol “[]”. The closing of this offering is conditioned upon Nasdaq’s final approval of our listing application, and there is no guarantee or assurance that our ordinary shares will be approved for listing on Nasdaq. Investing in our ordinary shares involves a high degree of risk, including the risk of losing your entire investment. See “Risk Factors” beginning on page 10 to read about factors you should consider before buying our ordinary shares. Our issued and outstanding share capital consists of ordinary shares. After the completion of this offering, Mr. Goh Kok Foong, our founder, chairman of board of directors and chief executive officer, will beneficially own []% of our total issued and outstanding ordinary shares and total voting power, assuming the option to purchase additional ordinary shares is not exercised by the underwriter. As a result, we will be a “controlled company” as defined under the Nasdaq Listing Rules. As a “controlled company,” we are permitted to elect not to comply with certain corporate governance requirements. See “ Risk Factors — Risks Related to Our Initial Public Offering and Ownership of Our Ordinary Shares — We are a “controlled company” within the meaning of the Nasdaq Listing Rules and, as a result, will rely on exemptions from certain corporate governance requirements that provide protection to shareholders of other companies.” We are an “emerging growth company” as defined under applicable U.S. securities laws and are eligible for reduced public company reporting requirements. Please read the disclosures beginning on page 4 of this prospectus for more information.

|                                  |     | Per Share |     | Total |
| Initial public offering price    |     | US$       |     | US$   |
| Underwriting discounts(1)        |     | US$       |     | US$   |
| Proceeds, before expenses, to us |     | US$       |     | US$   |

____________ (1)See “ Underwriting” in this prospectus for more information regarding our arrangements with the underwriter. [We have granted the underwriter an option for a period of 45 days from the date of closing of this offering to purchase up to 15% of the total number of the ordinary shares to be offered by us pursuant to this offering (excluding ordinary shares subject to this option), solely for the purpose of covering over -allotments, at the public offering price less the underwriting discounts.] If the underwriter exercises the option in full